FuseDiff: Symmetry-Preserving Joint Diffusion for Dual-Target Structure-Based Drug Design
Open Access
- 8 August 2026
- conference paper
- Published by Association for Computing Machinery (ACM)
- p. 12432-12443
Abstract
No abstract availableAll Related Versions
Funding Information
- National Natural Science Foundation (92470128)
- National Natural Science Foundation (U2241212)
- National Natural Science Foundation (61932001)
- National Natural Science Foundation (62302537)
- Guangdong Basic and Applied Basic Research Foundation (2025A1515012856)
This publication has 25 references indexed in Scilit:
- Geometric deep learning methods and applications in 3D structure-based drug designDrug Discovery Today, 2024
- Targeting protein kinases for the treatment of Alzheimer's disease: Recent progress and future perspectivesEuropean Journal of Medicinal Chemistry, 2023
- Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023
- Fast Local Alignment of Protein Pockets (FLAPP): A System-Compiled Program for Large-Scale Binding Site AlignmentJournal of Chemical Information and Modeling, 2022
- Polypharmacology: The science of multi-targeting moleculesPharmacological Research, 2022
- Three-Dimensional Convolutional Neural Networks and a Cross-Docked Data Set for Structure-Based Drug DesignJournal of Chemical Information and Modeling, 2020
- Dual-target kinase drug design: Current strategies and future directions in cancer therapyEuropean Journal of Medicinal Chemistry, 2020
- Binding MOAD (Mother Of All Databases)Proteins: Structure, Function, and Bioinformatics, 2005
- The Process of Structure-Based Drug DesignChemistry & Biology, 2003
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997